相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inflammatory Gene Expression Profile and Defective Interferon-γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients
Karen Put et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013
Jens Klotsche et al.
Arthritis & Rheumatology (2016)
Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?
Faekah Gohar et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity
Nanguneri Nirmala et al.
PEDIATRIC RHEUMATOLOGY (2015)
HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis
Michael J. Ombrello et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Distinctions Between Diagnostic and Classification Criteria?
Rohit Aggarwal et al.
ARTHRITIS CARE & RESEARCH (2015)
The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
Jaime Guzman et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort
Claudia Sengler et al.
RMD OPEN (2015)
Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis Results of a Prospective Cohort Study
Sebastiaan J. Vastert et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?
Peter A. Nigrovic
ARTHRITIS & RHEUMATOLOGY (2014)
2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications
Sarah Ringold et al.
ARTHRITIS AND RHEUMATISM (2013)
The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis
Dirk Holzinger et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
It is time to rethink juvenile idiopathic arthritis classification and nomenclature
Alberto Martini
ANNALS OF THE RHEUMATIC DISEASES (2012)
Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: Defining criteria based on the juvenile arthritis disease activity score
Alessandro Consolaro et al.
ARTHRITIS AND RHEUMATISM (2012)
Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis
Gregor Dueckers et al.
CLINICAL IMMUNOLOGY (2012)
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
Fabrizio De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Pierre Quartier et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Anakinra as First-Line Disease-Modifying Therapy in Systemic Juvenile Idiopathic Arthritis Report of Forty-Six Patients From an International Multicenter Series
Peter A. Nigrovic et al.
ARTHRITIS AND RHEUMATISM (2011)
Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions
Elizabeth D. Mellins et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Arthritic presentation of childhood malignancy: beware of normal blood counts
Deepti Suri et al.
RHEUMATOLOGY INTERNATIONAL (2011)
2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic Agents for the Treatment of Arthritis and Systemic Features
Timothy Beukelman et al.
ARTHRITIS CARE & RESEARCH (2011)
Treating rheumatoid arthritis to target: recommendations of an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
S100A12 Is a Novel Molecular Marker Differentiating Systemic-Onset Juvenile Idiopathic Arthritis From Other Causes of Fever of Unknown Origin
Helmut Wittkowski et al.
ARTHRITIS AND RHEUMATISM (2008)
The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis
Marco Gattorno et al.
ARTHRITIS AND RHEUMATISM (2008)
Quality improvement in pediatric rheumatology: what do we need to do?
Murray H. Passo et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Comparison of treatment strategies in early rheumatoid arthritis - A randomized trial
Yvonne P. M. Goekoop-Ruiterman et al.
ANNALS OF INTERNAL MEDICINE (2007)
Predictors of disease course and remission in systemic juvenile idiopathic arthritis - Significance of early clinical and laboratory features
D. Singh-Grewal et al.
ARTHRITIS AND RHEUMATISM (2006)
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
C Grigor et al.
LANCET (2004)
Incidence of occult cancer in children presenting with musculoskeletal symptoms: A 10-year survey in a pediatric rheumatology unit
S Trapani et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2000)
分享论文
